Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
Singapore · Delayed Price · Currency is SGD 0.0330
-0.0020 (-5.71%)
At close: Sep 16, 2025
SGXC:9G2 Revenue
In the fiscal year ending June 30, 2025, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.71M SGD, down -5.63%. Singapore Institute of Advanced Medicine Holdings had revenue of 7.67M in the half year ending June 30, 2025.
Revenue
15.71M
Revenue Growth
-5.63%
P/S Ratio
2.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 15.71M | -936.78K | -5.63% |
| Jun 30, 2024 | 16.65M | 412.41K | 2.54% |
| Jun 30, 2023 | 16.23M | 2.43M | 17.56% |
| Jun 30, 2022 | 13.81M | 891.35K | 6.90% |
| Jun 30, 2021 | 12.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DBS Group Holdings | 22.10B |
| Oversea-Chinese Banking Corporation | 13.72B |
| Singapore Telecommunications | 14.13B |
| United Overseas Bank | 13.32B |
| Singapore Technologies Engineering | 11.67B |
| Jardine Matheson Holdings | 45.30B |
| Singapore Airlines | 19.54B |
| Hongkong Land Holdings | 2.27B |